Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients

ByAdmin

Oct 31, 2023



The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.



Source link

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *